Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies

Journal of Affective Disorders

Volumn 117, Issue SUPPL. 1, 2009, Pages

  Kennedy, Sidney H ^a   Milev, Roumen ^b   Giacobbe, Peter ^a   Ramasubbu, Rajamannar ^c   Lam, Raymond W ^d   Parikh, Sagar V ^a   Patten, Scott B ^c   Ravindran, Arun V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Deep brain stimulation; Electroconvulsive therapy; Repetitive transcranial magnetic stimulation; Vagus nerve stimulation

Indexed keywords

ADULT; ARTICLE; BIBLIOGRAPHIC DATABASE; BRAIN DEPTH STIMULATION; CANADA; COUGHING; DYSPNEA; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED PRACTICE; HOARSENESS; HUMAN; MAJOR DEPRESSION; NERVE STIMULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAMPLE SIZE; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

ADULT; DEEP BRAIN STIMULATION; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

EID: 69649083323     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.06.039     Document Type: Article

References (98)

1. Abraham G., Milev R., Lazowski L., Jokic R., du Toit R., and Lowe A. Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression - an open label trial. Neuropsychiatric Disease and Treatment 3 (2007) 919-924
2. Appleby B.S., Duggan P.S., Regenberg A., and Rabins P.V. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov. Disord. 22 (2007) 1722-1728
3. Avery D.H., Holtzheimer P.E., Fawaz W., Russo J., Neumaier J., Dunner D.L., Haynor D.R., Claypoole K.H., Wajdik C., and Roy-Byrne P. Transcranial magnetic stimulation reduces pain in patients with major depression. J. Nerv. Ment. Dis. 195 (2007) 378-381
4. Bailine S.H., Rifkin A., and Kayne E. Comparison of bifrontal and bitemporal ECT for major depression. Am. J. Psychiatr. 157 (2000) 121-123
5. Brakemeier E., Luborzewski A., Danker-Hopfe H., Kathmann N., and Bajbouj M. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J. Psychiatr. Res. 41 (2007) 395-403
6. Bretlau L.G., Lunde M., Lindberg L., Unden M., Dissing S., and Bech P. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial. Pharmacopsychiatry 41 (2008) 41-47
7. Corcoran C.D., Thomas P., Philips J., and O'Keane V. Vagus nerve stimulation in chronic treatment-resistant depression: preliminary findings of an open-label study. Br. J. Psychiatry 189 (2006) 282-283
8. Couturier J.L. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. Rev. Psychiatr. Neurosci. 30 (2005) 83-90
9. Daskalakis J.Z., Levinson A.J., and Fitzgerald P.B. Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can. J. Psychiatry 53 (2008) 555-566
10. Devanand D.P., Dwork A.J., Hutchinson E.R., Bolwig T.G., and Sackeim H.A. Does ECT alter brain structure?. Am. J. Psychiatry 151 (1994) 957-970
11. Eranti S., Mogg A., Pluck G., Landau S., Purvis R., Brown R.G., Howard R., and Knapp M. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am. J. Psychiatry 164 (2007) 73-81
12. Eschweiler G.W., Vonthein R., Bode R., Huell M., Conca A., Peters O., Mende-Lechler S., Peters J., Klecha D., Prapotnik M., DiPauli J., Wild B., Plewnia C., Bartels M., and Schlotter W. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression. J. Affect. Disord. 101 (2007) 149-157
13. Fitzgerald P.B., and Daskalakis Z.J. The use of repetitive transcranial magnetic stimulation and vagal nerve stimulating in the treatment of depression. Curr. Opin. Psychiatry 21 (2008) 25-29
14. Fitzgerald P.B., Fountain S., and Daskalakis Z.J. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin. Neurophysiol. 117 (2006) 2584-2596
15. Fitzgerald P.B., Huntsman S., Gunewardene R., Kulkarni J., and Daskalkis Z.J. A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression. Int. J. Neuropsychopharmacol. 9 (2006) 655-666
16. Fitzgerald P.B., Hoy K., McQueen S., Maller J.J., Herring S., Segrave R., Bailey M., Bean G., Kulkarni J., and Daskalakis Z.J. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment resistant depression. Neuropsychopharmacology 34 (2009) 1255-1262
17. Flint A.J., and Rifat S.L. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT. Int. J. Geriatr. Psychiatry 13 (1998) 23-28
18. Fregni F., Ono C.R., Santos C.M., Bermpohl F., Buchpiguel C., Barbosa E.R., Marcolin M.A., Pascual-Leone A., and Valente K.D. Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD. Neurology 66 (2006) 1629-1637
19. George M.S., Rush A.J., Marangell L.B., Sackeim H.A., Brannan S.K., Davis S.M., Howland R., Kling M.A., Moreno F., Rittberg B., Dunner D., Schwartz T., Carpenter L., Burke M., Ninan P., and Goodnick P. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol. Psychiatry 58 (2005) 364-373
20. George M.S., Bohning D.E., Lorberbau J.P., Nahas Z., Anderson B., Borckardt J.J., Molnar C., Kose S., Ricci R., and Rastogi K. Overview of transcranial magnetic stimulation: history, mechanisms, physics and safety. Transcranial Magnetic Stimulation in Clinical Psychiatry (2007) 1-38
21. Gershon A.A., Dannon P.N., and Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am. J. Psychiatry 160 (2003) 835-845
22. Gross M., Nakamura L., Pascual-Leone A., and Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr. Scand. 116 (2007) 165-173
23. Grunhaus L., Schreiber S., Dolberg O.T., Hirshman S., and Dannon P.N. Response to ECT in major depression: are there differences between unipolar and bipolar depression?. Bipolar Disord. 4 Suppl.1 (2002) 91-93
24. Hoflich G., Kaper S., Hufnagal A., Ruhrmann S., and Moller H.J. Application of transcranial magnetic stimulation in treatment of drug-resistant major depression: a report of two cases. Hum. Psychopharmacol. 8 (1993) 361-365
25. Husain M.M., McClintock S.M., Rush A.J., and Knapp R.G. The efficacy of acute electroconvulsive therapy in atypical depression. J. Clin. Psychiatry 69 (2008) 406-411
26. Jorge R.E., Moser D.J., Action L., and Robinson R.G. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch. Gen. Psychiatry 65 (2008) 268-276
27. Keel J.C., Smith M.J., and Wassermann E.M. A safety screening questionnaire for transcranial magnetic stimulation (letter). Clin. Neurophysiol. 112 (2000) 720
28. Kellner C.H., Fink M., Knapp R., Petrides G., Husain M., Rummans T., Mueller M., Bernstein H., Rasmussen K., O'Connor K., Smith G., Rush A.J., Biggs M., McClintock S., Bailine S., and Malur C. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am. J. Psychiatry 162 (2005) 977-982
29. Kellner C., Knapp R.G., Petrides G., Rummans T.A., Husain M.M., Rasmussen K., Mueller M., Bernstein H.J., O'Connor K., Smith G., Biggs M., Bailine S.H., Malur C., Yim E., McClintock S., Sampson S., and Fink M. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression. Arch. Gen. Psychiatry 63 (2006) 1337-1344
30. In: Kennedy S.H., and Lam R.W. (Eds). Clinical Guidelines for the Treatment of Depressive Disorders. Can. J. Psychiatry vol. 46 Suppl. 1 (2001) 1S-92S
31. Kennedy S.H., Lam R.W., Parikh S.V., Patten S.B., and Ravindran A.V. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. J. Affect. Disord. 117 (2009) S1-S2
32. Kho K.H., Fink M., Rummans T.A., Ramussen K., Claassen C., Petrides G., Biggs M.M., Mueller M., Sampson S., Bailine S.H., Lisanby S.H., and Kellner C.H. A meta-analysis of electroconvulsive therapy efficacy in depression. J. ECT 19 (2003) 139-147
33. Knapp M., Romeo R., Moog A., Eranti S., Pluck G., Purvis R., Brown R.G., Howard R., Philpot M., Rothwell J., Edwards D., and McLoughlin D.M. Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: a multi-centre randomised controlled trial. J. Affect. Disord. 109 (2008) 273-285
34. Kotresh S., Girish K., Janakiramaiah N., Rao G.U., and Gangadhar B.N. Effect of ECT stimulus parameters on seizure physiology and outcome. J. ECT 20 (2004) 10-12
35. Kramer B.A. Use of ECT in California, revisited: 1984-1994. J. ECT 15 (1999) 245-251
36. Lam R.W., Chan P., Wilkins-Ho M., and Yatham L.N. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systemic review and meta-analysis. Can. J. Psychiatry 53 (2008) 621-631
37. Lisanby S.H., Maddox J.H., Prudic J., Devanand D.P., and Sackeim H.A. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch. Gen. Psychiatry 57 (2000) 581-590
38. Lisanby S.H., Husain M.M., Rosenquist P.B., Maixner D., Gutierrez R., Krystal A., Gilmer W., Marangell L.B., Aaronson S., Daskalakis Z.J., Canterbury R., Richelson E., Sackeim H.A., and George M.S. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 34 (2009) 522-534
39. Loo C.K., Mitchell P.B., McFarquhar T.F., Malhi G.S., and Sachdev S. A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression. Psychol. Med. 37 (2006) 349
40. Loo C.K., McFarquhar T.F., and Mitchell P.B. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int. J. Neuropsychopharmacol. 11 (2008) 131-147
41. Lozano A.M., Mayberg H.S., Giacobbe P., Hamani C., Craddock R.C., and Kennedy S.H. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol. Psychiatry 64 (2008) 461-467
42. Malone Jr. D.A., Dougherty D.D., Rezai A.R., Carpenter L.L., Friehs G.M., Eskandar E.N., Rauch S.L., Rasmussen S.A., Machado A.G., Kubu C.S., Tyrka A.R., Price L.H., Stypulkowski P.H., Giftakis J.E., Rise M.T., Malloy P.F., Salloway S.P., and Greenberg B.D. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol. Psychiatry 65 (2009) 267-275
43. Marangell L.B., Rush A.J., George M.S., Sackeim H.A., Johnson C.R., Husain M.M., Nahas Z., and Lisanby S.H. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol. Psychiatry 51 (2002) 280-287
44. Marano C.M., Phatak P., Vemulapalli U.R., Sasan A., Nalbandyan M.R., Ramanujam S., Soekadar S., Demosthenous M., and Regenold W.T. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. J. Clin. Psychiatry 68 (2007) 512-517
45. Martin J.L., Barbanoj M.J., Schlaepfer T.E., Thompson E., Perez V., and Kulisevsky J. Repetitive transcranial magnetic stimulation for the treatment of depression. Br. J. Psychiatry 182 (2003) 480-491
46. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull. 65 (2003) 193-207
47. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., Schwalb J.M., and Kennedy S.H. Deep brain stimulation for treatment-resistant depression. Neuron 45 (2005) 651-660
48. McNeely H.E., Mayberg H.S., Lozano A.M., and Kennedy S.H. Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. J. Nerv. Ment. Dis. 196 (2008) 405-410
49. Milev R., Abraham G., Hasey G., and Casaj J. Repetitive transcranial magnetic stimulation for treatment of medicine-resistant depression in older adults. J. ECT 25 (2009) 44-49
50. Moser D.J., Jorge R.E., Manes F., Paradiso S., Benjamin M.L., and Robinson R.G. Improved executive functioning following repetitive transcranial magnetic stimulation. Neurology 58 (2002) 1288-1290
51. Mosimann U.P., Schmitt W., Greenberg B.D., Kosel M., Muri R.M., Berkhoff M., Hess C.W., Fisch H.U., Falkai P., and Schlaepfer T.E. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res. 126 (2004) 123-133
52. Nahas Z., Marangell L.B., Husain M.M., Rush A.J., Sackeim H.A., Lisanby S.H., Martinez J.M., and George M.S. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J. Clin. Psychiatry 66 (2005) 1097-1104
53. Nahas Z., Kozel F.A., Molnar C., Ramsey D., Holt R., Ricci R., Johnson K.A., Koola J., and George M.S. Methods of administering transcranial magnetic stimulation. Transcranial Magnetic Stimulation in Clinical Psychiatry (2008), American Psychiatric Publishing, Inc. 39-57
54. Neimat J.S., Hamani C., Giacobbe P., Merskey H., Kennedy S.H., Mayberg H.S., and Lozano A.M. Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. Am. J. Psychiatry 165 (2008) 687-693
55. Nemeroff C.B., Mayberg H.S., Krahl S.E., McNamara J., Frazer A., Henry T.R., George M.S., Charney D.S., and Brannan S.K. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanism. Neuropsychopharmacology 31 (2006) 1345-1355
56. Nierenberg A.A., Alpert J.E., Gardner-Schuster E.E., Seay S., and Mischoulon D. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol. Psychiatry 64 (2008) 455-460
57. O'Connor M., Lebowitz B.K., Ly J., Panizzon M.S., Elkin-Frankston S., Dey S., Bloomingdale K., Thall M., and Pearlman C. A dissociation between anterograde and retrograde amnesia after treatment with electroconvulsive therapy: a naturalistic investigation. J. ECT 24 (2008) 146-151
58. O'Reardon J.P., Blumner K.H., Peshek A.D., Pradilla R.R., and Pimiento P.C. Long-term maintenance therapy for major depressive disorder with rTMS. J. Clin. Psychiatry 66 (2005) 1524-1528
59. O'Reardon J.P., Cristancho P., and Peshek A.D. Vagus nerve stimulation (VNS) and treatment of depression to the brainstem and beyond. Psychiatry 3 (2006) 54-63
60. O'Reardon J.P., Solvasonm H.B., Janicak P.G., Sampson S., Isenberg K.E., Nahas Z., McDonald W.M., Avery D.H., Fitzgerald P.B., Loo C.K., Demitrack M.A., George M.S., and Sackeim H.A. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol. Psychiatry 62 (2007) 1208-1216
61. Pagnin D., de Queiroz V., Pini S., and Cassano G.B. Efficacy of ECT in depression: a meta-analytic review. J. ECT 20 (2004) 13-20
62. Petrides G., Fink M., Husain M.M., Knapp R.G., Rush A.J., Mueller M., Rummans T.A., O'Connor K.M., Rasmussen Jr. K.G., Bernstein H.J., Biggs M., Bailine S.H., and Kellner C.H. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J. ECT 17 (2001) 244-253
63. Porter R., Heenan H., and Reeves J. Early effects of electroconvulsive therapy on cognitive function. J. ECT 24 (2008) 35-39
64. Poulet E., Brunelin J., Boeuve C., Lerond J., D'Amato T., Dalery J., and Saoud H. Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment. Eur. Psychiatr. 19 (2004) 382-383
65. Prudic J., Haskett R.F., Mulsant B., Malone K.M., Pettinati H.M., Stephens S., Greenberg R., Rifat S.L., and Sackeim H.A. Resistance to antidepressant medications and short-term clinical response to ECT. Am. J. Psychiatry 153 (1996) 985-992
66. Rabheru K., and Persad E. A review of continuation and maintenance electroconvulsive therapy. Can. J. Psychiatry 42 (1997) 476-484
67. Rado J., and Janicak P.G. Vagus nerve stimulation for severe depression. J. Psychosoc. Nurs. Ment. Health Serv. 45 (2007) 43-51
68. Rasmussen K., Mueller M., Knapp R.G., Husain M.M., Rummans T.A., Sampson S.M., O'Connor K., Petrides G., Fink M., and Kellner C.H. Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapy. J. Clin. Psychiatry 68 (2007) 1701-1706
69. Rosa M.A., Gattaz W.F., Pascual-Leone A., Fregni F., Rosa M.O., Rumi D.O., Myczkowski M.L., Silva J.F., Mansur C., Rigonatti S.P., Teixeira M.J., and Marcolin M.A. Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study. Int. J. Neuropsychopharmacol. 9 (2006) 667-676
70. Rossini D., Magri L., Lucca A., Giordani S., Smeraldi E., and Zanardi R. Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. J. Clin. Psychiatry 66 (2005) 1569-1575
71. Rumi D.O., Gattaz W.F., Rigonatti S.P., Rosa M.A., Fregni F., Rosa M.O., Mansur C., Myczkowski M.L., Moreno R.A., and Marcolin M.A. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol. Psychiatry 57 (2005) 166
72. Rush A.J., George M.S., Sackeim H.A., Marangell L.B., Husain M.M., Giller C., Nahas Z., Haines S., Simpson Jr. R.K., and Goodman R. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol. Psychiatry 47 (2000) 276-286
73. Rush A.J., Marangell L.B., Sackeim H.A., George M.S., Brannan S.K., Davis S.M., Howland R., Kling M.A., Rittberg B.R., Burke W.J., Rapaport M.H., Zajecka J., Nierenberg A.A., Husain M.M., Ginsberg D., and Cooke R.G. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol. Psychiatry 58 (2005) 347-354
74. Rush A.J., Sackeim H.A., Marangell L.B., George M.S., Brannan S.K., Davis S.M., Lavori P., Howland R., Kling M.A., Rittberg B., Carpenter L., Ninan P., Moreno F., Schwartz T., Conway C., Burke M., and Barry J.J. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol. Psychiatry 58 (2005) 355-363
75. Sackeim H.A. Convulsant and anticonvulsant properties of electroconvulsive therapy: towards a focal form of brain stimulation. Clin. Neurosci. Res. 4 (2004) 39-57
76. Sackeim H.A., Decina P., Kanzler M., Kerr B., and Malitz S. Effects of electrode placement on the efficacy of titrated, low dose ECT. Am. J. Psychiatry 144 (1987) 1449-1455
77. Sackeim H.A., Prudic J., Devanand D.P., Kiersky J.E., Fitzsimons L., Moody B.J., McElhiney M.C., Coleman E.A., and Settembrino J.M. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N. Eng. J. Med. 328 (1993) 839-846
78. Sackeim H.A., Prudic J., Devanand D.P., Nobler M.S., Lisanby S.H., Peyser S., Fitzsimons L., Moody B.J., and Clark J. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch. Gen. Psychiatry 57 (2000) 425-434
79. Sackeim H.A., Haskett R.F., Mulsant B.H., Thase M.E., Mann J.J., Pettinati H.M., Greenberg R.M., Crowe R.R., Cooper T.B., and Prudic J. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. J. Am. Med. Assoc. 285 (2001) 1299-1307
80. Sackeim H.A., Keilp J.G., Rush A.J., George M.S., Marangell L.B., Dormerm J.S., Burt T., Lisanby S.H., Husain M., Cullum C.M., Oliver N., and Zboyan H. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol. Behav. Neurol. 14 (2001) 53-62
81. Sackeim H.A., Rush A.J., George M.S., Marangell L.B., Husain M.M., Nahas Z., Johnson C.R., Seidman S., Giller C., Haines S., Simpson Jr. R.K., and Goodman R.R. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25 (2001) 713-728
82. Sackeim H.A., Prudic J., Fuller R., Keilp J., Lavori P.W., and Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 32 (2007) 244-254
83. Sackeim H.A., Prudic J., Nobler M.S., Fitzsimons L., Lisanby S.H., Payne N., Berman R.M., Brakemeier E.L., Perera T., and Devanand D.P. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stim. 1 (2008) 71-83
84. Sackeim H.A., Dillingham E.M., Prudic J., Cooper T., McCall W.V., Rosenquist P., Isenberg K., Garcia K., Mulsant B.H., and Haskett R.F. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch. Gen. Psychiatry 66 (2009) 729-737
85. Schlaepfer T.E., Cohen M.X., Frick C., Kosel M., Brodesser D., Axmacher N., Joe A.Y., Kreft M., Lenartz D., and Strum V. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychoparmachology 33 (2008) 368-377
86. Schlaepfer T.E., Frick C., Zobel A., Maier W., Heuser I., Bajbouj M., O'Keane V., Corcoran C., Adolfsson R., Trimble M., Rau H., Hoff H.J., Padberg F., Müller-Siecheneder F., Audenaert K., Van den Abbeele D., Stanga Z., and Hasdemir M. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol. Med. 38 (2008) 651-661
87. Schule C., Zwanzger P., Baghai T., Mikhaiel P., Thoma H., Moller J., Rupprecht R., and Padberg F. Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study. J. Psychiatr. Res. 37 (2003) 145-153
88. Schulze-Rauschenbach S.C., Harms U., Schlaepfer T.E., Maier W., Falkai P., and Wagner M. Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. Br. J. Psychiatry 186 (2005) 410-416
89. Schutter D.J. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol. Med. 30 (2008) 1-11
90. Shapira B., Tubi N., and Lerer B. Balancing speed of response to ECT in major depression and adverse cognitive effects: role of treatment schedule. J. ECT 169 (2000) 97-109
91. Stoppe A., Louza M., Rosa M., Gil G., and Rigonatti S. Fixed high-dose electroconvulsive therapy in the elderly with depression: a double-blind, randomized comparison of efficacy and tolerability between unilateral and bilateral electrode placement. J. ECT 22 (2006) 92-99
92. Stoudemire A., Hill C.D., Marquardt M., Dalton S., and Lewison B.J. Recovery and relapse in geriatric depression after treatment with antidepressants and ECT in a medical-psychiatric population. Gen. Hosp. Psych. 20 (1998) 170-174
93. The UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361 (2003) 799-808
94. Vothnecht S., van Schaick H.W., Middelkoop H., and Blansjaar B.A. Effects of maintenance electroconvulsive therapy on cognitive functions. J. ECT 19 (2003) 151-157
95. Wijeratne C., Halliday G.S., and Lyndon R.W. The present status of electroconvulsive therapy: a systematic review. Med. J. Aust. 171 (1999) 250-254
96. Yatham L.N., Kennedy S.H., Schaffer A., Parikh S.V., Beaulieu S., O'Donovan C., MacQueen G.M., McIntyre R.S., Sharma V., Ravindran A., Young L.T., Young A.H., Alda M., Milev R., Vieta E., Calabrese J.R., Berk M., Ha K., and Kapczinski F. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 11 (2009) 225-255
97. Zachrisson O.C.G., Balldin J., Ekman R., Naesh O., Rosengren L., Agren H., and Blennow K. No evident neuronal damage after electroconvulsive therapy. Psychiatry Res. 96 (2000) 157-165
98. Zanardi R., Magri L., Rossini D., Malaguti A., Giordani S., Lorenzi C., Pirovano A., Smeraldi E., and Lucca A. Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression. Eur. Neuropsychopharmacol. 17 (2007) 651-657